Advertisement

Index by author

August 01, 1992; Volume 42,Issue 2

A

  1. Ades, A M

    1. Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
      S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1992, 42 (2) 217-226;

  2. Aiyar, N

    1. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
      P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott
      Molecular Pharmacology August 1992, 42 (2) 336-339;

  3. Andre, C

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

B

  1. Barbour, K W

    1. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
      K W Barbour, D K Hoganson, S H Berger and F G Berger
      Molecular Pharmacology August 1992, 42 (2) 242-248;

  2. Basu, H S

    1. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
      L Ghoda, H S Basu, C W Porter, L J Marton and P Coffino
      Molecular Pharmacology August 1992, 42 (2) 302-306;

  3. Beaune, P H

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

  4. Belloc, C

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

  5. Berger, F G

    1. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
      K W Barbour, D K Hoganson, S H Berger and F G Berger
      Molecular Pharmacology August 1992, 42 (2) 242-248;

  6. Berger, S H

    1. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
      K W Barbour, D K Hoganson, S H Berger and F G Berger
      Molecular Pharmacology August 1992, 42 (2) 242-248;

  7. Biagi, B A

    1. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
      J J Enyeart, B A Biagi and B Mlinar
      Molecular Pharmacology August 1992, 42 (2) 364-372;

  8. Blair, I A

    1. Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
      A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird
      Molecular Pharmacology August 1992, 42 (2) 175-179;

  9. Blakeman, D P

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

  10. Bleakman, D

    1. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
      D Bleakman, K I Rusin, P S Chard, S R Glaum and R J Miller
      Molecular Pharmacology August 1992, 42 (2) 192-196;

  11. Bockaert, J

    1. Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
      O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert
      Molecular Pharmacology August 1992, 42 (2) 322-327;

  12. Bourdi, M

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

  13. Branchek, T A

    1. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
      J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank
      Molecular Pharmacology August 1992, 42 (2) 180-185;

  14. Bryan, H

    1. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
      P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott
      Molecular Pharmacology August 1992, 42 (2) 336-339;

  15. Buschauer, A

    1. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
      R Seifert, A Höer, S Offermanns, A Buschauer and W Schunack
      Molecular Pharmacology August 1992, 42 (2) 227-234;
    2. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
      R Seifert, A Höer, I Schwaner and A Buschauer
      Molecular Pharmacology August 1992, 42 (2) 235-241;

C

  1. Campillo, M

    1. Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
      J Giraldo, M Martín, M Campillo and L Pardo
      Molecular Pharmacology August 1992, 42 (2) 373-381;

  2. Carter, D B

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

  3. Chard, P S

    1. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
      D Bleakman, K I Rusin, P S Chard, S R Glaum and R J Miller
      Molecular Pharmacology August 1992, 42 (2) 192-196;

  4. Christophe, J

    1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
      P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
      Molecular Pharmacology August 1992, 42 (2) 347-355;

  5. Chuang, D M

    1. N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells.
      D M Chuang, X M Gao and S M Paul
      Molecular Pharmacology August 1992, 42 (2) 210-216;

  6. Coffino, P

    1. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
      L Ghoda, H S Basu, C W Porter, L J Marton and P Coffino
      Molecular Pharmacology August 1992, 42 (2) 302-306;

  7. Cragoe, E J

    1. Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
      A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird
      Molecular Pharmacology August 1992, 42 (2) 175-179;

  8. Curry, K

    1. Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
      O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert
      Molecular Pharmacology August 1992, 42 (2) 322-327;

D

  1. De Neef, P

    1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
      P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
      Molecular Pharmacology August 1992, 42 (2) 347-355;

  2. Dooley, T P

    1. Sequence analysis, in vitro translation, and expression of the cDNA for rat liver minoxidil sulfotransferase.
      S J Hirshey, T P Dooley, I M Reardon, R L Heinrikson and C N Falany
      Molecular Pharmacology August 1992, 42 (2) 257-264;

E

  1. el-Fakahany, E E

    1. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
      J Hu, S Z Wang, C Forray and E E el-Fakahany
      Molecular Pharmacology August 1992, 42 (2) 311-321;

  2. Elliott, J

    1. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
      P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott
      Molecular Pharmacology August 1992, 42 (2) 336-339;

  3. Enyeart, J J

    1. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
      J J Enyeart, B A Biagi and B Mlinar
      Molecular Pharmacology August 1992, 42 (2) 364-372;

F

  1. Falany, C N

    1. Sequence analysis, in vitro translation, and expression of the cDNA for rat liver minoxidil sulfotransferase.
      S J Hirshey, T P Dooley, I M Reardon, R L Heinrikson and C N Falany
      Molecular Pharmacology August 1992, 42 (2) 257-264;

  2. Fisher, S K

    1. Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
      S K Fisher, E L McEwen, S C Lovell and R E Landon
      Molecular Pharmacology August 1992, 42 (2) 340-346;

  3. Fluharty, S J

    1. Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
      S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1992, 42 (2) 217-226;

  4. Forray, C

    1. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
      J Hu, S Z Wang, C Forray and E E el-Fakahany
      Molecular Pharmacology August 1992, 42 (2) 311-321;

G

  1. Gao, X M

    1. N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells.
      D M Chuang, X M Gao and S M Paul
      Molecular Pharmacology August 1992, 42 (2) 210-216;

  2. Gautier, J C

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

  3. Ghoda, L

    1. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
      L Ghoda, H S Basu, C W Porter, L J Marton and P Coffino
      Molecular Pharmacology August 1992, 42 (2) 302-306;

  4. Giraldo, J

    1. Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
      J Giraldo, M Martín, M Campillo and L Pardo
      Molecular Pharmacology August 1992, 42 (2) 373-381;

  5. Glaum, S R

    1. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
      D Bleakman, K I Rusin, P S Chard, S R Glaum and R J Miller
      Molecular Pharmacology August 1992, 42 (2) 192-196;

  6. Gorospe, E

    1. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
      S Leonhardt, E Gorospe, B J Hoffman and M Teitler
      Molecular Pharmacology August 1992, 42 (2) 328-335;

  7. Gourlet, P

    1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
      P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
      Molecular Pharmacology August 1992, 42 (2) 347-355;

  8. Guillouzo, A

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

H

  1. Hales, T G

    1. Immortalized hypothalamic GT1-7 neurons express functional gamma-aminobutyric acid type A receptors.
      T G Hales, H Kim, B Longoni, R W Olsen and A J Tobin
      Molecular Pharmacology August 1992, 42 (2) 197-202;

  2. Hamilton, B J

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

  3. Hartig, P R

    1. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
      J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank
      Molecular Pharmacology August 1992, 42 (2) 180-185;

  4. Heinrikson, R L

    1. Sequence analysis, in vitro translation, and expression of the cDNA for rat liver minoxidil sulfotransferase.
      S J Hirshey, T P Dooley, I M Reardon, R L Heinrikson and C N Falany
      Molecular Pharmacology August 1992, 42 (2) 257-264;

  5. Hirshey, S J

    1. Sequence analysis, in vitro translation, and expression of the cDNA for rat liver minoxidil sulfotransferase.
      S J Hirshey, T P Dooley, I M Reardon, R L Heinrikson and C N Falany
      Molecular Pharmacology August 1992, 42 (2) 257-264;

  6. Höer, A

    1. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
      R Seifert, A Höer, S Offermanns, A Buschauer and W Schunack
      Molecular Pharmacology August 1992, 42 (2) 227-234;
    2. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
      R Seifert, A Höer, I Schwaner and A Buschauer
      Molecular Pharmacology August 1992, 42 (2) 235-241;

  7. Hoffman, B J

    1. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
      S Leonhardt, E Gorospe, B J Hoffman and M Teitler
      Molecular Pharmacology August 1992, 42 (2) 328-335;

  8. Hoganson, D K

    1. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
      K W Barbour, D K Hoganson, S H Berger and F G Berger
      Molecular Pharmacology August 1992, 42 (2) 242-248;

  9. Hollenberg, M D

    1. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
      M D Hollenberg, S G Yang, A A Laniyonu, G J Moore and M Saifeddine
      Molecular Pharmacology August 1992, 42 (2) 186-191;

  10. Hu, J

    1. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
      J Hu, S Z Wang, C Forray and E E el-Fakahany
      Molecular Pharmacology August 1992, 42 (2) 311-321;

I

  1. Im, H K

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

  2. Im, W B

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

J

  1. Jackson, B

    1. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
      R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston
      Molecular Pharmacology August 1992, 42 (2) 286-293;

  2. Jacobsen, E J

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

  3. Johnston, C I

    1. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
      R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston
      Molecular Pharmacology August 1992, 42 (2) 286-293;

  4. Jones, G S

    1. Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
      Y Xie, G S Jones and R H Loring
      Molecular Pharmacology August 1992, 42 (2) 356-363;

K

  1. Kim, H

    1. Immortalized hypothalamic GT1-7 neurons express functional gamma-aminobutyric acid type A receptors.
      T G Hales, H Kim, B Longoni, R W Olsen and A J Tobin
      Molecular Pharmacology August 1992, 42 (2) 197-202;

  2. Kim, S G

    1. Transcriptional regulation of rat microsomal epoxide hydrolase gene by imidazole antimycotic agents.
      S G Kim
      Molecular Pharmacology August 1992, 42 (2) 273-279;

  3. Kimmett, S M

    1. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
      S M Kimmett, R A Whitney and G S Marks
      Molecular Pharmacology August 1992, 42 (2) 307-310;

L

  1. Landon, R E

    1. Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
      S K Fisher, E L McEwen, S C Lovell and R E Landon
      Molecular Pharmacology August 1992, 42 (2) 340-346;

  2. Laniyonu, A A

    1. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
      M D Hollenberg, S G Yang, A A Laniyonu, G J Moore and M Saifeddine
      Molecular Pharmacology August 1992, 42 (2) 186-191;

  3. Larrey, D

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

  4. Leonhardt, S

    1. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
      S Leonhardt, E Gorospe, B J Hoffman and M Teitler
      Molecular Pharmacology August 1992, 42 (2) 328-335;

  5. Levy, G N

    1. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
      K J Martell, G N Levy and W W Weber
      Molecular Pharmacology August 1992, 42 (2) 265-272;

  6. Limbird, L E

    1. Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
      A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird
      Molecular Pharmacology August 1992, 42 (2) 175-179;

  7. Longoni, B

    1. Immortalized hypothalamic GT1-7 neurons express functional gamma-aminobutyric acid type A receptors.
      T G Hales, H Kim, B Longoni, R W Olsen and A J Tobin
      Molecular Pharmacology August 1992, 42 (2) 197-202;

  8. Loring, R H

    1. Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
      Y Xie, G S Jones and R H Loring
      Molecular Pharmacology August 1992, 42 (2) 356-363;

  9. Lovell, S C

    1. Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
      S K Fisher, E L McEwen, S C Lovell and R E Landon
      Molecular Pharmacology August 1992, 42 (2) 340-346;

M

  1. Macchi, M

    1. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
      J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank
      Molecular Pharmacology August 1992, 42 (2) 180-185;

  2. Mah, S J

    1. Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
      S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1992, 42 (2) 217-226;

  3. Manzoni, O

    1. Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
      O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert
      Molecular Pharmacology August 1992, 42 (2) 322-327;

  4. Marks, G S

    1. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
      S M Kimmett, R A Whitney and G S Marks
      Molecular Pharmacology August 1992, 42 (2) 307-310;

  5. Martell, K J

    1. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
      K J Martell, G N Levy and W W Weber
      Molecular Pharmacology August 1992, 42 (2) 265-272;

  6. Martín, M

    1. Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
      J Giraldo, M Martín, M Campillo and L Pardo
      Molecular Pharmacology August 1992, 42 (2) 373-381;

  7. Marton, L J

    1. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
      L Ghoda, H S Basu, C W Porter, L J Marton and P Coffino
      Molecular Pharmacology August 1992, 42 (2) 302-306;

  8. McEwen, E L

    1. Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
      S K Fisher, E L McEwen, S C Lovell and R E Landon
      Molecular Pharmacology August 1992, 42 (2) 340-346;

  9. Mendelsohn, F A

    1. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
      R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston
      Molecular Pharmacology August 1992, 42 (2) 286-293;

  10. Miller, R J

    1. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
      D Bleakman, K I Rusin, P S Chard, S R Glaum and R J Miller
      Molecular Pharmacology August 1992, 42 (2) 192-196;

  11. Mir, R

    1. Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
      S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1992, 42 (2) 217-226;

  12. Mircheva, J

    1. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
      M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
      Molecular Pharmacology August 1992, 42 (2) 280-285;

  13. Mlinar, B

    1. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
      J J Enyeart, B A Biagi and B Mlinar
      Molecular Pharmacology August 1992, 42 (2) 364-372;

  14. Moore, G J

    1. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
      M D Hollenberg, S G Yang, A A Laniyonu, G J Moore and M Saifeddine
      Molecular Pharmacology August 1992, 42 (2) 186-191;

N

  1. Nambi, P

    1. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
      P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott
      Molecular Pharmacology August 1992, 42 (2) 336-339;

O

  1. Offermanns, S

    1. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
      R Seifert, A Höer, S Offermanns, A Buschauer and W Schunack
      Molecular Pharmacology August 1992, 42 (2) 227-234;

  2. Olsen, R W

    1. Immortalized hypothalamic GT1-7 neurons express functional gamma-aminobutyric acid type A receptors.
      T G Hales, H Kim, B Longoni, R W Olsen and A J Tobin
      Molecular Pharmacology August 1992, 42 (2) 197-202;

  3. Omiecinski, C J

    1. Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene.
      C J Omiecinski, R Ramsden, A Rampersaud and F G Walz
      Molecular Pharmacology August 1992, 42 (2) 249-256;

  4. Oswald, R E

    1. Biochemical characterization of kainate receptors from goldfish brain.
      C J Ziegra, J M Willard and R E Oswald
      Molecular Pharmacology August 1992, 42 (2) 203-209;

P

  1. Pardo, L

    1. Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
      J Giraldo, M Martín, M Campillo and L Pardo
      Molecular Pharmacology August 1992, 42 (2) 373-381;

  2. Paul, S M

    1. N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells.
      D M Chuang, X M Gao and S M Paul
      Molecular Pharmacology August 1992, 42 (2) 210-216;

  3. Paxton, D

    1. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
      R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston
      Molecular Pharmacology August 1992, 42 (2) 286-293;

  4. Perich, R B

    1. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
      R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston
      Molecular Pharmacology August 1992, 42 (2) 286-293;

  5. Petke, J D

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

  6. Porter, C W

    1. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
      L Ghoda, H S Basu, C W Porter, L J Marton and P Coffino
      Molecular Pharmacology August 1992, 42 (2) 302-306;

  7. Prakash, C

    1. Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
      A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird
      Molecular Pharmacology August 1992, 42 (2) 175-179;

  8. Pregenzer, J F

    1. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
      J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
      Molecular Pharmacology August 1992, 42 (2) 294-301;

  9. Prezeau, L

    1. Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
      O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert
      Molecular Pharmacology August 1992, 42 (2) 322-327;

  10. Pullen, M

    1. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
      P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott
      Molecular Pharmacology August 1992, 42 (2) 336-339;

R

  1. Rampersaud, A

    1. Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene.
      C J Omiecinski, R Ramsden, A Rampersaud and F G Walz
      Molecular Pharmacology August 1992, 42 (2) 249-256;

  2. Ramsden, R

    1. Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene.
      C J Omiecinski, R Ramsden, A Rampersaud and F G Walz
      Molecular Pharmacology August 1992, 42 (2) 249-256;

  3. Rassendren, F A

    1. Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
      O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert
      Molecular Pharmacology August 1992, 42 (2) 322-327;

  4. Reardon, I M

    1. Sequence analysis, in vitro translation, and expression of the cDNA for rat liver minoxidil sulfotransferase.
      S J Hirshey, T P Dooley, I M Reardon, R L Heinrikson and C N Falany
      Molecular Pharmacology August 1992, 42 (2) 257-264;

  5. Robberecht, P

    1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
      P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
      Molecular Pharmacology August 1992, 42 (2) 347-355;

  6. Rogerson, F

    1. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
      R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston
      Molecular Pharmacology August 1992, 42 (2) 286-293;

  7. Rusin, K I

    1. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
      D Bleakman, K I Rusin, P S Chard, S R Glaum and R J Miller
      Molecular Pharmacology August 1992, 42 (2) 192-196;

S

  1. Saifeddine, M

    1. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
      M D Hollenberg, S G Yang, A A Laniyonu, G J Moore and M Saifeddine
      Molecular Pharmacology August 1992, 42 (2) 186-191;

  2. Schechter, L E

    1. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
      J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank
      Molecular Pharmacology August 1992, 42 (2) 180-185;

  3. Schunack, W

    1. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
      R Seifert, A Höer, S Offermanns, A Buschauer and W Schunack
      Molecular Pharmacology August 1992, 42 (2) 227-234;

  4. Schwaner, I

    1. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
      R Seifert, A Höer, I Schwaner and A Buschauer
      Molecular Pharmacology August 1992, 42 (2) 235-241;

  5. Seifert, R

    1. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
      R Seifert, A Höer, S Offermanns, A Buschauer and W Schunack
      Molecular Pharmacology August 1992, 42 (2) 227-234;
    2. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
      R Seifert, A Höer, I Schwaner and A Buschauer
      Molecular Pharmacology August 1992, 42 (2) 235-241;

  6. Siemens, I R

    1. Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
      S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1992, 42 (2) 217-226;

  7. Sladeczek, F

    1. Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
      O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert
      Molecular Pharmacology August 1992, 42 (2) 322-327;

T

  1. Teitler, M

    1. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
      S Leonhardt, E Gorospe, B J Hoffman and M Teitler
      Molecular Pharmacology August 1992, 42 (2) 328-335;

  2. Tobin, A J

    1. Immortalized hypothalamic GT1-7 neurons express functional gamma-aminobutyric acid type A receptors.
      T G Hales, H Kim, B Longoni, R W Olsen and A J Tobin
      Molecular Pharmacology August 1992, 42 (2) 197-202;

V

  1. Vandermeers, A

    1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
      P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
      Molecular Pharmacology August 1992, 42 (2) 347-355;

  2. Vandermeers-Piret, M C

    1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
      P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
      Molecular Pharmacology August 1992, 42 (2) 347-355;

W

  1. Walz, F G

    1. Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene.
      C J Omiecinski, R Ramsden, A Rampersaud and F G Walz
      Molecular Pharmacology August 1992, 42 (2) 249-256;

  2. Wang, S Z

    1. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
      J Hu, S Z Wang, C Forray and E E el-Fakahany
      Molecular Pharmacology August 1992, 42 (2) 311-321;

  3. Weber, W W

    1. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
      K J Martell, G N Levy and W W Weber
      Molecular Pharmacology August 1992, 42 (2) 265-272;

  4. Weinshank, R L

    1. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
      J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank
      Molecular Pharmacology August 1992, 42 (2) 180-185;

  5. Whitney, R A

    1. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
      S M Kimmett, R A Whitney and G S Marks
      Molecular Pharmacology August 1992, 42 (2) 307-310;

  6. Willard, J M

    1. Biochemical characterization of kainate receptors from goldfish brain.
      C J Ziegra, J M Willard and R E Oswald
      Molecular Pharmacology August 1992, 42 (2) 203-209;

  7. Williamson, J R

    1. Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
      S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1992, 42 (2) 217-226;

  8. Wilson, A L

    1. Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
      A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird
      Molecular Pharmacology August 1992, 42 (2) 175-179;

  9. Womble, S W

    1. Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
      A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird
      Molecular Pharmacology August 1992, 42 (2) 175-179;

  10. Woussen-Colle, M C

    1. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
      P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
      Molecular Pharmacology August 1992, 42 (2) 347-355;

  11. Wu, H L

    1. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
      P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott
      Molecular Pharmacology August 1992, 42 (2) 336-339;

X

  1. Xie, Y

    1. Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
      Y Xie, G S Jones and R H Loring
      Molecular Pharmacology August 1992, 42 (2) 356-363;

Y

  1. Yang, S G

    1. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
      M D Hollenberg, S G Yang, A A Laniyonu, G J Moore and M Saifeddine
      Molecular Pharmacology August 1992, 42 (2) 186-191;

Z

  1. Zgombick, J M

    1. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
      J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank
      Molecular Pharmacology August 1992, 42 (2) 180-185;

  2. Ziegra, C J

    1. Biochemical characterization of kainate receptors from goldfish brain.
      C J Ziegra, J M Willard and R E Oswald
      Molecular Pharmacology August 1992, 42 (2) 203-209;
Back to top

In this issue